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RNA-containing vesicles, recovered from the supernatant of high-density cell samples of human colon carcinoma, pro- 
duce a high-resolution 1H NMR spectrum of lipids characterized by isotropic tumbling; these vesicles contain large 
amounts of triglycerides and cholesterol esters. Both findings have strict analogies to what is displayed by the proteolipid 
complexes i olated from the sera of tumor-bearing patients [(1985) Proc. Natl. Acad. Sci. USA 82, 3455-3459; (1986) 
FEBS Lett. 203, 164-I 68]. Lipid analysis and enzymatic tests indicate that these vesicles are selected micromaps of plasma 
membranes, analogous to those that can be recovered from culture media in which tumor cells are grown [(1985) Dev. 
Biol. 3, 33-57]. Peculiar lipids, an acylated oligopeptide and a modified phospholipid, are also present in the vesicles. 
Vesicle shedding; Lipid analysis; NMR; (Tumor cell) 
1. INTRODUCTION 
The well-assessed phenomenon of vesicle shed- 
ding from tumor cells [1] deserves much attention 
mainly in relation to the observation that similar 
membrane vesicles [2] or RNA-proteolipid com- 
plexes [3-5] circulate in the blood of patients with 
cancer. Our previous work [6-8] has demonstrated 
that RNA is present in vesicles released from the 
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Abbreviations." PL, phospholipids; PC, phosphatidylcholine; 
SM, sphingomyelin; PS, phosphatidylserine; PS, modified 
phosphatidylserine; PE, phosphatidylethanolamine; TG, 
triglycerides; LPC, lysophosphatidylcholine; VC, vesicles from 
cells; VM, vesicles from cytoplasm-deprived cells; VDC, 
vesicles from exhausted cells; VRC, vesicles from partially 
restored cells; HPTLC, high-performance thin-layer 
chromatography; TLC/GLC, thin-layer chromatography/gas- 
liquid chromatography 
plasma membrane of human colon carcinoma 
cells, namely HCT-8R [9]. Preliminary ex- 
periments [10] indicate that the same structures are 
released from LS-174T cells derived from the same 
tumor [11]. 
Here, the lipid composition of the structures 
released by HCT-8R cells has been analyzed in 
great detail with the aim of their further 
characterization. According to current knowledge 
on vesicle shedding [12-14], they consist of 
selected micromaps of plasma me.mbrane; further- 
more, they contain large amounts of triglycerides 
and cholesterol esters. Two uncommon lipids have 
also been found. The first is an acylated oligopep- 
tide, not related to the known classes of acylated 
proteins of eukaryotic ells. The second is a 
phospholipid metabolically related to the former. 
These findings are discussed in view of the 
analogies with t e complexes found in the sera 
[2-5] and those isolated from the culture media of 
cells [1]. 
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2. MATERIALS AND METHODS 
HCT-8R cells, from human adenocarcinoma [9], were grown 
as described [6,7]. Confluent cells (3 x l0 s per experiment) were 
detached with 3 mM EDTA, washed and suspended in 1 ml of 
150 mM NaCI to achieve vesicle release [7]. 
Cytoplasm-deprived cells were prepared from confluent cells 
upon freezing at - 80°C for 60 rain. The lysed cells were then 
centrifuged at 800 x g, extensively washed with 150 mM NaCI 
and finally resuspended in 150 mM NaCI for vesicle release. 
Plasma membranes were isolated according to Lerner et al. 
[13] with minor modifications. 
Enzymatic tests and protein determination were performed as 
in [7]. 
Lipids were extracted from lyophilized supernatants using 
chloroform/methanol  (2: 1, v/v) [15]. The fatty acid composi- 
tion of the major phospholipid classes was determined by 
TLC/GLC [16]. Methyl esters of all the phospholipid classes 
were prepared by acid-catalyzed transesterification as follows: 
1 ml of 3 N methanolic HC1 (Supelco, Bellafonte, PA) was add- 
ed and the tubes were left o stand for 18 h at 50°C, then 1 ml 
of water and the fatty acid methyl esters were extracted twice 
with 3 ml hexane/diethyl ether (1 : 1, v/v). 
Quantitative determination of phospholipid classes was per- 
formed by densitometric s anning of HPTLC plates [17], based 
on molybdenum reagent for lipid phosphorus. The identity of 
the bands individuated by one-dimensional TLC has been con- 
firmed by two-dimensional TLC with specific reagents for 
phosphorus, amino groups, carbohydrates and sialic acid 
residues, as described by Christie [18]. 
Cholesterol present in the lipid extracts was recovered from 
TLC scrapings of the band moving with the solvent front. Its 
quantitative determination was performed on an isopropanol 
solution by using a commercial enzymatic kit (Boehringer, 
Biochemio Robin, Milan). 
The fatty acid composition and quantitative stimation of 
triacylglycerols were determined by TLC-GLC, as described by 
Christie [19]. 
The new lipid compound, not containing phosphorus, was 
quantitated on the basis of its fatty acid content. 
Amino acid analysis of the new compound was carried out, 
after hydrolysis with 6 N HCI at 105°C overnight [20], by 
HPLC (Waters, Manual no.CU85999, Milford, MA). 
IH NMR spectra were recorded on a Bruker AM 400 spec- 
trometer, at 400 MHz. 20 mM EDTA in 2H20 was added 
before measurements. The water signal was partially suppressed 
by gated irradiation of its proton signal. Chemical shifts are 
referred to external DSS. 
3. RESULTS AND DISCUSSION 
The supernatant of HCT-8R cells shows narrow 
lipid resonances in the ~H NMR spectrum (fig. 1: a, 
partially relaxed spectrum to minimize the lactate 
signal; b, fully relaxed spectrum). These signals are 
analogous to those attributed to acyl chains of 
neutral lipids of a proteolipid complex isolated 
from the sera of tumor-bearing patients [5] and to 
those originating from the plasma membrane of 
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Fig.1. (a) IH NMR spectra of vesicles released by intact 
HCT-8R cells at room temperature by using an inversion 
recovery sequence to minimize the lactate signal; (b) fully 
relaxed spectrum. 
tumor cells [6,21]. Therefore, we attribute the 
signals in fig. la to lipids present in vesicles released 
by cancer cells. A contribution of phospholipids, 
besides neutral ipids, to the 1H NMR spectrum is 
suggested by 3~p NMR: a phosphodiester signal 
around -0 .5  ppm from H3PO4 is always present 
in the spectrum of this sample and is produced, to 
an extent of at least 30%, by phospholipid 
molecules [7]. 
The lipid composition of vesicles released by in- 
tact cells (VC) is reported in table I. In agreement 
with data on the complex isolated by Mountford et 
al. [5] from sera of tumor patients, large amounts 
of triglycerides (TG) have been found. The 
phospholipid (PL) content of the vesicles is only 
slightly affected by cytoplasm deprivation of cells 
(VM) (table 1). Similar cholesterol (Ch) to lipid 
ratios were observed for VC and VM samples 
(table 1). The release process appeared to reach 
completion at 40 min as the new saline solution 
replaced after this time (VDC) did not contain 
lipids (table 1). However, these exhausted cells 
were able to restore partially the shedding process 
if allowed to recover metabolism and pH neutrality 
by maintaining them in serum-free culture medium 
continuously bubbled with 5% CO2 in air (VRC, 
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Table l 
Lipid content of vesicles released at room temperature by 
HCT-SR cells (VC) 
VC a VC4 ° VM VDC VRC 
PL b~g) 19.3 _+ 0.5 n.d. 16.7 _+ 0.5 n.d. 8.3 _ 0.5 
Ch (ag) b 7.6 _+ 1.0 n.d. 7.1 _+ 1.0 n.d. 7.3 _+ 1.0 
TG ~g) 10.0 _+ 1.0 n.d. 
Unknown 
lipid (~g) 1.6 _+ 0.5 n.d. 1.8 _+ 0.5 n.d. 1.4 _+ 0.5 
When the cell sample was vortex-mixed during the shedding 
time, the amount of released material was approximately 
triplicate, maintaining the same relative ratios among the 
different molecules 
b Ch is partially esterified 
Data on vesicles released by cytoplasm-deprived c lls (VM), 
exhausted cells (VDC), partially recovered cells (VRC) and a 
cell sample maintained at 4°C during the release (VC4 °) are 
given for purposes of comparison. All data are the averages of 
at least three independent measurements, n.d., not detectable 
table 1). When the cell suspension is held at 4°C, 
the release process is inhibited and no vesicles can 
be found in the supernatant  ( able 1), in agreement 
with previous f indings on vesicles recovered from 
culture media [22]. 
H igher  alkal ine phosphatase activity observed in 
vesicle samples compared  to p lasma membrane 
(table 2) indicates that vesicles are selected do- 
mains of  p lasma membranes.  Contaminat ion  by 
endoplasmic  ret iculum (ER) can be excluded on 
the basis of  the lack o f  the ER marker  NADH-  
cytochrome reductase in both p lasma membrane 
and released vesicles. Similar results were reported 
by Lerner et al. [13] on vesicles recovered from 
culture medium of  dif ferent tumor  cells. 
The p lasma membrane composi t ion (fig.2) is 
Table 2 
Enzymatic activities of plasma membranes (PM), vesicles 
released by HCT-SR cells at room temperature (VC), and 
vesicles released by cytoplasm-deprived cells (VM) 
PM VC" VM a 
NADH-cytochrome 
reductase 0 0 0 
Alkaline phosphatase 1.0 7.7 8.6 
" From [7] 
Activities are related to mg proteins 
[ ]  phosphatidylcholine 
100 [ ]  phosphatidylethanolamine 
[ ]  sphingomyelin 
m phosphatidylserine 
[ ]  unkncwn lipid 
[ ]  ly SO pho sphalidylcholina 
50 
oiN 
a b C tl 
Fig.2. Phospholipid composition of (a) isolated plasma 
membranes of HCT-SR cells; (b) VC; (c) VM; (d) VRC. 
Phosphatidylserine is PS in b-d. 
character ized by a high sphingomyel in (SM) con- 
tent, in agreement with publ ished data on the l ipid 
composi t ion of  p lasma membranes from eukaryo-  
tic cells [23]. The PL  composi t ion of  vesicles 
released by intact cells (fig.2b) reveals the presence 
of  lysophosphat idy lchol ine (LPC),  most l ikely due 
to part ia l  degradat ion o f  phosphat idylchol ine (PC) 
by some phosphol ipase active during the release 
process. A higher concentrat ion of  SM is also 
present in these vesicles as compared to the cor- 
responding p lasma membranes.  Similar results are 
obta ined in VM (fig.2c) and VRC (fig.2d) samples. 
The high SM content found in the vesicles provides 
addit ional  experimental  evidence that they are shed 
by the p lasma membrane as selected l ipid domains 
with an unusual  composit ion,  very similar, in 
terms of  l ipid analysis, to that of  vesicles f rom dif- 
ferent tumor  cells [12]. 
A PL  fraction, with the same one-dimensional  
TLC  mobi l i ty  as that of  PS or phosphat idyl inos i to l  
standards,  is present in all vesicle samples. This 
fract ion has been indicated as PS in the fol lowing, 
but neither the specific spray reagents nor two- 
d imensional  TLC conf i rmed the identity with the 
above-ment ioned standards.  Its solubi l i ty in 
organic solvents is very similar to that of  PS. 
Another  l ipid, not containing phosphorus,  
detected using I2 vapour ,  with the one-dimensional  
mobi l i ty  of  GM1 ganglioside, has been indicated as 
an unknown l ipid (fig.3a). This compound does 
not contain carbohydrate  and sialic acid residues, 
27 
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Fig.3. TLC of lipids extracted from vesicles released by HCT-8R cells (VC), detected by I2 vapour, (a) One-dimensional TLC of all 
lipids; the arrow indicates the unknown lipid (due to the heterogeneous composition of the fatty acid chains, PC and PE migrate at 
higher ates than the standards). (b) Two-dimensional TLC of the unknown lipid; its spot is indicated by the arrow (the other spot 
is a phospholipid, sometimes scraped together with the unknown compound). 
as shown by negative staining with the specific 
reagents and migrates as a single spot in two- 
dimensional TLC (fig.3b). The presence of a short 
oligopeptide chain as the head group of this 
peculiar molecule has been demonstrated by amino 
acid analysis following acid hydrolysis. Table 3 
lists the amino acid composition of the oligopep- 
tide moiety. Large quantities of the basic amino 
Table 3 
Amino acid composition (expressed as mol%) of the 
oligopeptide moiety of the unknown lipid found in the vesicles 
Amino acid mol% 
Asn 4.1 
Thr 2.1 
Ser 5.7 
Glu 9.0 
Gly 3.0 
Ala 4.0 
Leu 10.0 
Phe 6.0 
His 31.0 
Lys 22.0 
Arg 3.4 
acids Lys and His were found but acidic residues 
are also well represented. 
Preliminary experiments on PS also demon- 
strated the presence of amino acid residues, mainly 
Lys and His, in its head group. Analysis of the 
structure of this compound, recovered on the TLC 
plate, indicates that this is actually a family of 
closely related molecules, the study of which is cur- 
rently in progress, requiring further work. 
Table 4 shows the relative fatty acid composition 
of the phospholipids and the unknown compound. 
Table 4 
Fatty acid composition of vesicles released by HCT-8R cells 
a b c 
PC 64.6 31.6 5.1 
LPC 65.5 30.2 4.3 
PE 70.0 26.0 4.2 
SM 72.0 26.3 2.2 
PS 61.0 36.4 2.5 
Unknown lipid 59.8 36.4 3.8 
Data are averages of at least three independent measurements. 
(a) Saturated, (b) monosaturated, (c) polyunsaturated 
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SM and PE display the highest amount  of  
saturated chains, while the strict similarit ies in 
percentages of  double bonds observed for PS and 
the unknown lipid suggest a close relat ionship be- 
tween their metabol ic  patterns. 
4. CONCLUSIONS 
The vesicles recovered f rom the supernatant  of  
HCT-8R cell samples are selected micromaps of  
the p lasma membrane,  as demonstrated by both 
enzyme and l ipid analysis (table 2 and fig.2). We 
have, therefore,  demonstrated that very similar 
structures can be isolated f rom the supernatants of  
high-density cell samples and from cell culture 
media,  as per formed usual ly [12-14].  
Some structural  similarit ies exist for the vesicles 
descr ibed here and the proteol ip id complex 
isolated f rom sera, in part icular  the high TG and 
cholesterol  ester content found in the released 
vesicles (table 1) and serum proteol ip id complex 
[5]. Bearing in mind that RNA is also bound to the 
vesicles released by HCT-8R cells [7,8], we suggest 
that an as yet unexplained link exists between the 
presence of  an RNA-proteo l ip id  complex in sera of  
tumor-bear ing patients [5] and the very general 
phenomenon of  vesicle shedding from tumor  cells. 
Another  relevant result is the f inding that un- 
common compounds  are recovered in large 
amounts  f rom the vesicle sample. These com- 
pounds  do not seem to be related to the known 
classes of  acylated proteins (recent review [24]). 
Due to the similarit ies in the degree of  saturat ion 
of  the fatty acid chains of  PS and of  the new lipid, 
we are investigating the connect ions between the 
two molecules. This point  deserves further in- 
vestigation in view of  a possible function of  these 
compounds  as membrane anchors,  as has been 
suggested for many membrane phosphat idyl inos i -  
to l -anchored proteins [25]. 
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